
The global Companion Animal Diagnostics market size was valued at US$ 2039.6 million in 2023. With growing demand in downstream market, the Companion Animal Diagnostics is forecast to a readjusted size of US$ 3704.8 million by 2030 with a CAGR of 8.9% during review period.
The research report highlights the growth potential of the global Companion Animal Diagnostics market. Companion Animal Diagnostics are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Companion Animal Diagnostics. 麻豆原创 players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Companion Animal Diagnostics market.
Companion Animal Diagnostic provide a competitive, fully interpreted, quality assured, accredited (UKAS ISO 17025 certification) clinical pathology/pathology service for companion animals including canine, feline, equine, avian, small mammals and exotics.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from 拢2.6bn in 2015 to 拢4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about 楼67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 17%.
Key Features:
The report on Companion Animal Diagnostics market reflects various aspects and provide valuable insights into the industry.
麻豆原创 Size and Growth: The research report provide an overview of the current size and growth of the Companion Animal Diagnostics market. It may include historical data, market segmentation by Type (e.g., Clinical Biochemistry, Urinalysis), and regional breakdowns.
麻豆原创 Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Companion Animal Diagnostics market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Companion Animal Diagnostics market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Companion Animal Diagnostics industry. This include advancements in Companion Animal Diagnostics technology, Companion Animal Diagnostics new entrants, Companion Animal Diagnostics new investment, and other innovations that are shaping the future of Companion Animal Diagnostics.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Companion Animal Diagnostics market. It includes factors influencing customer ' purchasing decisions, preferences for Companion Animal Diagnostics product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Companion Animal Diagnostics market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Companion Animal Diagnostics market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Companion Animal Diagnostics market.
麻豆原创 Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Companion Animal Diagnostics industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Companion Animal Diagnostics market.
麻豆原创 Segmentation:
Companion Animal Diagnostics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Clinical Biochemistry
Urinalysis
Immunodiagnostic
Hematology
Molecular Diagnostics
Segmentation by application
Clinical Pathology
Bacteriology
Parasitology
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
IDEXX Laboratories
Zoetis
Thermo Fisher Scientific
Virbac
Heska Corporation
Neogen Corporation
bioM茅rieux SA
IDvet
INDICAL Bioscience GmbH
Randox Laboratories
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Companion Animal Diagnostics 麻豆原创 Size 2019-2030
2.1.2 Companion Animal Diagnostics 麻豆原创 Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Companion Animal Diagnostics Segment by Type
2.2.1 Clinical Biochemistry
2.2.2 Urinalysis
2.2.3 Immunodiagnostic
2.2.4 Hematology
2.2.5 Molecular Diagnostics
2.3 Companion Animal Diagnostics 麻豆原创 Size by Type
2.3.1 Companion Animal Diagnostics 麻豆原创 Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Companion Animal Diagnostics 麻豆原创 Size 麻豆原创 Share by Type (2019-2024)
2.4 Companion Animal Diagnostics Segment by Application
2.4.1 Clinical Pathology
2.4.2 Bacteriology
2.4.3 Parasitology
2.5 Companion Animal Diagnostics 麻豆原创 Size by Application
2.5.1 Companion Animal Diagnostics 麻豆原创 Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Companion Animal Diagnostics 麻豆原创 Size 麻豆原创 Share by Application (2019-2024)
3 Companion Animal Diagnostics 麻豆原创 Size by Player
3.1 Companion Animal Diagnostics 麻豆原创 Size 麻豆原创 Share by Players
3.1.1 Global Companion Animal Diagnostics Revenue by Players (2019-2024)
3.1.2 Global Companion Animal Diagnostics Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Companion Animal Diagnostics Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Companion Animal Diagnostics by Regions
4.1 Companion Animal Diagnostics 麻豆原创 Size by Regions (2019-2024)
4.2 Americas Companion Animal Diagnostics 麻豆原创 Size Growth (2019-2024)
4.3 APAC Companion Animal Diagnostics 麻豆原创 Size Growth (2019-2024)
4.4 Europe Companion Animal Diagnostics 麻豆原创 Size Growth (2019-2024)
4.5 Middle East & Africa Companion Animal Diagnostics 麻豆原创 Size Growth (2019-2024)
5 Americas
5.1 Americas Companion Animal Diagnostics 麻豆原创 Size by Country (2019-2024)
5.2 Americas Companion Animal Diagnostics 麻豆原创 Size by Type (2019-2024)
5.3 Americas Companion Animal Diagnostics 麻豆原创 Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Companion Animal Diagnostics 麻豆原创 Size by Region (2019-2024)
6.2 APAC Companion Animal Diagnostics 麻豆原创 Size by Type (2019-2024)
6.3 APAC Companion Animal Diagnostics 麻豆原创 Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Companion Animal Diagnostics by Country (2019-2024)
7.2 Europe Companion Animal Diagnostics 麻豆原创 Size by Type (2019-2024)
7.3 Europe Companion Animal Diagnostics 麻豆原创 Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Companion Animal Diagnostics by Region (2019-2024)
8.2 Middle East & Africa Companion Animal Diagnostics 麻豆原创 Size by Type (2019-2024)
8.3 Middle East & Africa Companion Animal Diagnostics 麻豆原创 Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Global Companion Animal Diagnostics 麻豆原创 Forecast
10.1 Global Companion Animal Diagnostics Forecast by Regions (2025-2030)
10.1.1 Global Companion Animal Diagnostics Forecast by Regions (2025-2030)
10.1.2 Americas Companion Animal Diagnostics Forecast
10.1.3 APAC Companion Animal Diagnostics Forecast
10.1.4 Europe Companion Animal Diagnostics Forecast
10.1.5 Middle East & Africa Companion Animal Diagnostics Forecast
10.2 Americas Companion Animal Diagnostics Forecast by Country (2025-2030)
10.2.1 United States Companion Animal Diagnostics 麻豆原创 Forecast
10.2.2 Canada Companion Animal Diagnostics 麻豆原创 Forecast
10.2.3 Mexico Companion Animal Diagnostics 麻豆原创 Forecast
10.2.4 Brazil Companion Animal Diagnostics 麻豆原创 Forecast
10.3 APAC Companion Animal Diagnostics Forecast by Region (2025-2030)
10.3.1 China Companion Animal Diagnostics 麻豆原创 Forecast
10.3.2 Japan Companion Animal Diagnostics 麻豆原创 Forecast
10.3.3 Korea Companion Animal Diagnostics 麻豆原创 Forecast
10.3.4 Southeast Asia Companion Animal Diagnostics 麻豆原创 Forecast
10.3.5 India Companion Animal Diagnostics 麻豆原创 Forecast
10.3.6 Australia Companion Animal Diagnostics 麻豆原创 Forecast
10.4 Europe Companion Animal Diagnostics Forecast by Country (2025-2030)
10.4.1 Germany Companion Animal Diagnostics 麻豆原创 Forecast
10.4.2 France Companion Animal Diagnostics 麻豆原创 Forecast
10.4.3 UK Companion Animal Diagnostics 麻豆原创 Forecast
10.4.4 Italy Companion Animal Diagnostics 麻豆原创 Forecast
10.4.5 Russia Companion Animal Diagnostics 麻豆原创 Forecast
10.5 Middle East & Africa Companion Animal Diagnostics Forecast by Region (2025-2030)
10.5.1 Egypt Companion Animal Diagnostics 麻豆原创 Forecast
10.5.2 South Africa Companion Animal Diagnostics 麻豆原创 Forecast
10.5.3 Israel Companion Animal Diagnostics 麻豆原创 Forecast
10.5.4 Turkey Companion Animal Diagnostics 麻豆原创 Forecast
10.5.5 GCC Countries Companion Animal Diagnostics 麻豆原创 Forecast
10.6 Global Companion Animal Diagnostics Forecast by Type (2025-2030)
10.7 Global Companion Animal Diagnostics Forecast by Application (2025-2030)
11 Key Players Analysis
11.1 IDEXX Laboratories
11.1.1 IDEXX Laboratories Company Information
11.1.2 IDEXX Laboratories Companion Animal Diagnostics Product Offered
11.1.3 IDEXX Laboratories Companion Animal Diagnostics Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.1.4 IDEXX Laboratories Main Business Overview
11.1.5 IDEXX Laboratories Latest Developments
11.2 Zoetis
11.2.1 Zoetis Company Information
11.2.2 Zoetis Companion Animal Diagnostics Product Offered
11.2.3 Zoetis Companion Animal Diagnostics Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.2.4 Zoetis Main Business Overview
11.2.5 Zoetis Latest Developments
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Information
11.3.2 Thermo Fisher Scientific Companion Animal Diagnostics Product Offered
11.3.3 Thermo Fisher Scientific Companion Animal Diagnostics Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.3.4 Thermo Fisher Scientific Main Business Overview
11.3.5 Thermo Fisher Scientific Latest Developments
11.4 Virbac
11.4.1 Virbac Company Information
11.4.2 Virbac Companion Animal Diagnostics Product Offered
11.4.3 Virbac Companion Animal Diagnostics Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.4.4 Virbac Main Business Overview
11.4.5 Virbac Latest Developments
11.5 Heska Corporation
11.5.1 Heska Corporation Company Information
11.5.2 Heska Corporation Companion Animal Diagnostics Product Offered
11.5.3 Heska Corporation Companion Animal Diagnostics Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.5.4 Heska Corporation Main Business Overview
11.5.5 Heska Corporation Latest Developments
11.6 Neogen Corporation
11.6.1 Neogen Corporation Company Information
11.6.2 Neogen Corporation Companion Animal Diagnostics Product Offered
11.6.3 Neogen Corporation Companion Animal Diagnostics Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.6.4 Neogen Corporation Main Business Overview
11.6.5 Neogen Corporation Latest Developments
11.7 bioM茅rieux SA
11.7.1 bioM茅rieux SA Company Information
11.7.2 bioM茅rieux SA Companion Animal Diagnostics Product Offered
11.7.3 bioM茅rieux SA Companion Animal Diagnostics Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.7.4 bioM茅rieux SA Main Business Overview
11.7.5 bioM茅rieux SA Latest Developments
11.8 IDvet
11.8.1 IDvet Company Information
11.8.2 IDvet Companion Animal Diagnostics Product Offered
11.8.3 IDvet Companion Animal Diagnostics Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.8.4 IDvet Main Business Overview
11.8.5 IDvet Latest Developments
11.9 INDICAL Bioscience GmbH
11.9.1 INDICAL Bioscience GmbH Company Information
11.9.2 INDICAL Bioscience GmbH Companion Animal Diagnostics Product Offered
11.9.3 INDICAL Bioscience GmbH Companion Animal Diagnostics Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.9.4 INDICAL Bioscience GmbH Main Business Overview
11.9.5 INDICAL Bioscience GmbH Latest Developments
11.10 Randox Laboratories
11.10.1 Randox Laboratories Company Information
11.10.2 Randox Laboratories Companion Animal Diagnostics Product Offered
11.10.3 Randox Laboratories Companion Animal Diagnostics Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.10.4 Randox Laboratories Main Business Overview
11.10.5 Randox Laboratories Latest Developments
12 Research Findings and Conclusion
听
听
*If Applicable.
